BindingDB logo
myBDB logout

77 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review
PMIDDataArticle TitleOrganization
 8 Acyliminothiadiazoline derivatives: New, highly potent, and orally active angiotensin II receptor antagonistsEBI TBA
 31 Uracil-based angiotensin II receptor antagonistsEBI TBA
 50 The SAR of 6-(N-alkyl-N-acyl)-2-propyl-3-[(2′-tetrazol-5-yl)biphen-4-yl)methyl]-quinazolinones as balanced affinity antagonists of the human AT1 and AT2 receptorsEBI TBA
 3 D and L-N-[(1-benzyl-1H-imidazol-5-yl)-alkyl]-amino acids as angiotensin II AT-1 antagonistsEBI TBA
 53 Potent triazolinone-based angiotensin II receptor antagonists with equivalent affinity for both the AT1 and AT2 subtypesEBI TBA
 24 Discovery of nonpeptide potent conformationally restricted angiotensin II receptor antagonistsEBI TBA
 113 Development of angiotensin II antagonists with equipotent affinity for human AT1 and AT2 receptor subtypes.EBI TBA
 122 Balanced angiotensin II receptor antagonists. III. The effects of substitution at the imidazole 5-position.EBI TBA
 68 Balanced angiotensin II receptor antagonists. II.1,2 4-aminomethyl- and acylaminomethylimidazolesEBI TBA
 19 Imidazolinones as nonpeptide angiotensin II receptor antagonistsEBI TBA
 11 Valsartan, a potent, orally active angiotensin II antagonist developed from the structurally new amino acid seriesEBI TBA
 12 A potent long-acting imidazole-5-acrylic acid angiotensin II AT-1 receptor antagonistEBI TBA
 1 Orally active prodrugs of quinoline-4-carboxylic acid angiotensin II receptor antagonistsEBI TBA
 12 Quinoline-4-carboxylic acids as angiotensin II receptor antagonistsEBI TBA
 16 Dihydro-imidazolone derivatives as angiotensin II receptor antagonists: chiral effect on the activityEBI TBA
 6 Cyclopentanespiro-3H-dihydro-pyrimidinones as Angiotensin II AT1 receptor antagonistsEBI TBA
 19 Triazolinones as nonpeptide angiotensin II antagonists. 2. discovery of a potent and orally active triazolinone acylsulfonamideEBI TBA